Fever is a common adverse reaction to vaccination, contributing to vaccine hesitancy and reduced uptake. To understand variation in fever risk, we longitudinally profiled fecal microbiota, oral temper...

Our conversation on his new book BLOCKERS

Our conversation on his new book BORDERS

Clairity Breast, an A.I. tool that can predict five-year risk of developing breast cancer, is rolling out nationwide. Here’s what experts want you to know.

Menopause is an important biological transition with up to 72 symptoms that shapes aging trajectories across organs and encompasses ~40% of the female lifespan. Although menopause awareness is increas...

That’s What Biological (Epigenetic) Aging Clocks Are Measuring

Federal officials are drafting an executive order that would place grants under review by an outside panel, the latest effort to redirect billions of dollars in research spending.

U.S. President Donald Trump is seeking to bring ​a major part of national funding for health ‌research under the control of his political appointees, Politico reported on Saturday.

A Gaping Lack of Evidence for Health Benefits

A new survey found that 8 in 10 Americans were taking vitamins, protein powders or other supplements. But experts said many offer little to no benefit.

Objective We aimed to assess the association between COVID-19 vaccination status and COVID-19-related hospital admissions, need for mechanical ventilation or extracorporeal membrane oxygenation (ECM...

YouTube video by The Daily Show

Wellness clinics are shooting people up with vitamins, but is the point to actually feel better — or the opposite?

How Two Large Outcome Trials Based on Surrogate Metrics Failed

Hundreds of millions of people have long-term conditions as a result of an infection. Researchers are working out how to help them.

In this Perspective, Christopher Winchester and colleagues discuss how open access options for publishing commercially-funded research are often restricted, examine the consequences of this inequity, ...

Long Covid saps the strength and vitality of patients, who have little recourse to fight it. A team of specialists—including an afflicted researcher working mostly from her bed—is looking for answers

here are the papers! https://www.nature.com/articles/s41586-026-10939-0 https://www.science.org/doi/10.1126/science.adt8307

Lead Authors Julia Belk and Nathan Zemke Discuss and Translate their Findings

The shots have been approved for people 65 and older, and for younger people with underlying conditions. Others may be able to get them off label.

Weight-loss drugs, peptides, I.V.F. As sharps migrate out of doctors’ offices, even needle-phobics are willing to embrace shots.